Summarize with:
Hyderabad: The Hyderabad-based biotech company, Bharat Biotech is developing the vaccine in collaboration with the ICMR. It has started human trials on its vaccine candidate, ‘Covaxin’, which is India’s first indigenous COVID-19 vaccine. It is working to develop an initial capacity of 200 million vials of the vaccine.
The World Health Organisation (WHO) and its alliance partners, including the vaccine alliance GAVI, have said the goal is to create 2 billion doses of coronavirus vaccine by 2021.
It is to be noted that India’s Covid-19 caseload has crossed the 8.5 lakh mark. The rapid spread of the pandemic has seen the country’s share in daily global cases rise to 12%.
Summarize with:
Discussion about this post